alpha-aminopyridine has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamis, AP; Knolle, J; Löffler, KU; Stragies, R; Vossmeyer, D; Wills, M; Wong, CG; Zahn, G | 1 |
| Akiyama, H; Campochiaro, PA; Kachi, S; Stragies, R; Umeda, N; Vossmeyer, D; Zahn, G | 1 |
2 other study(ies) available for alpha-aminopyridine and Choroid Neovascularization
| Article | Year |
|---|---|
Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Topics: Aminopyridines; Angiogenesis Inhibitors; Animals; beta-Alanine; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroretinography; Female; Fibroblast Growth Factor 2; Fluorescein Angiography; Injections; Integrin alpha5beta1; Macaca fascicularis; Male; Rabbits; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist.
Topics: Administration, Cutaneous; Alanine; Aminopyridines; Animals; Apoptosis; Blood Vessels; Bruch Membrane; Choroidal Neovascularization; Drug Delivery Systems; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Integrin alpha5beta1; Mice; Mice, Inbred C57BL; Phosphorylation; Up-Regulation; Vitreous Body | 2006 |